Recent Research and Future Directions in IDH-Mutant Gliomas
Written by
Cancer Network
Published
0
comments
0
min
Panelists discuss how voracidinib shows superior brain penetration compared to other IDH inhibitors and explore exciting combination approaches with immunotherapy and vaccines that target the immunosuppressive effects of 2-HG in the tumor microenvironment.